Neovasc Wins German Court Appeal; Announces German Court's Decision to Dismiss CardiAQ's Claim to Co-inventorship of a European Patent for Tiara(TM)

VANCOUVER, March 21, 2019 -- (Healthcare Sales & Marketing Network) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technol... Devices, Interventional, Cardiology, Litigation Neovasc, Edwards Lifesciences, CardiAQ, Tiara , mitral bioprosthesis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news